Recruiting Influenza Studies in San Diego
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma....
About Influenza Clinical Trials in San Diego
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It causes millions of illnesses and thousands of deaths annually. Prevention through vaccination is the primary strategy, with antiviral medications available for treatment.
There are currently 2 influenza clinical trials recruiting participants in San Diego, CALIFORNIA. These studies are seeking a combined 2,763 participants. Research is being sponsored by BioNTech SE, Giselle Sholler. Clinical trial participation is free and participants receive study-related medical care at no cost.
Influenza Clinical Trials in San Diego — FAQ
Are there influenza clinical trials in San Diego?
Yes, there are 2 influenza clinical trials currently recruiting in San Diego, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Diego?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.
Are clinical trials in San Diego free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.
What influenza treatments are being tested?
The 2 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for influenza.
Data updated March 2, 2026 from ClinicalTrials.gov